Live-Suche
TopFind ruft die neuesten Treffer für deine Suche ab.
Wir haben 6 Live-Ergebnisse für herzuma geprüft und auf 3 Optionen eingegrenzt, die sich zuerst am meisten zum Vergleichen eignen.
Die stärksten Themen in dieser Auswahlliste sind Oncology und Biosimilar.
Quelle: Celltrion Healthcare Philippines Inc.
Beschreibung
Herzuma is a biosimilar used in the treatment of HER2-positive cancers, providing a high-quality alternative to reference biologics.
Am besten für
HER2 Positive cancer, Oncology therapy und Biosimilar oncology
Bewertung
Quelle: Celltrion Healthcare Singapore Private Limited
Beschreibung
Herzuma is a trastuzumab biosimilar referencing Herceptin, registered in Singapore for treating HER2-positive breast and gastric cancers. It provides a clinically comparable treatment option that is supported by local health subsidies.
Am besten für
HER2 Positive cancer care, Breast cancer patients und Affordable trastuzumab access
Bewertung
Quelle: Celltrion Healthcare
Beschreibung
Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials.
Am besten für
HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy und Oncology infusion treatment
Bewertung
| Vergleichen | Herzuma (Trastuzumab) | Herzuma | Herzuma (Trastuzumab) |
|---|---|---|---|
| Quelle | Celltrion Healthcare Philippines Inc. | Celltrion Healthcare Singapore Private Limited | Celltrion Healthcare |
| Beschreibung | Herzuma is a biosimilar used in the treatment of HER2-positive cancers, providing a high-quality alternative to reference biologics. | Herzuma is a trastuzumab biosimilar referencing Herceptin, registered in Singapore for treating HER2-positive breast and gastric cancers. It provides a clinically comparable treatment option that is supported by local health subsidies. | Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials. |
| Am besten für | HER2 Positive cancer, Oncology therapy und Biosimilar oncology | HER2 Positive cancer care, Breast cancer patients und Affordable trastuzumab access | HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy und Oncology infusion treatment |
| Aktion | |||
| Bewertung |
Wenn du mit der ausgewogensten Option starten möchtest, empfehle ich:
"Herzuma (Trastuzumab) von Celltrion Healthcare Philippines Inc.."
Ich habe dies ausgewählt, weil Herzuma offers a clinically validated biosimilar option for patients with HER2-positive oncological conditions.